Low cardiac output associated with ventricular tachyarrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT Study).

@article{Cantillon2014LowCO,
  title={Low cardiac output associated with ventricular tachyarrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT Study).},
  author={Daniel J. Cantillon and Walid I. Saliba and Oussama Musbah Wazni and Mohamed H Kanj and Randall C. Starling and W. H. Wilson Tang and Bruce L Wilkoff},
  journal={The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation},
  year={2014},
  volume={33 3},
  pages={
          318-20
        }
}
duration of 381 days of LVAD support (range 9 to 1,670 days). The mean duration off warfarin was 392 days (range 31 to 1,980 days). The total cumulative time off warfarin was 15 patient-years. Of the 14 patients, 5 (35.7%) have been off warfarin for at least 1 year. One patient had a pump thrombus due to device malpositioning that required a device exchange after being off warfarin for 1.3 years. After discontinuing warfarin, there were no additional adverse thromboembolic, hemolytic or… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 11 references

Intraoperative evaluation of the HeartMate II flow estimator.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation • 2009
View 3 Excerpts
Highly Influenced

Increased incidence of gastrointestinal bleeding following implantation of the HeartMate II LVAD

DR Stern, J Kazam, S Shariff
J Card Surg • 2009

Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation • 2009